Microbial Contamination Leads to Dr. Reddy's Recall

- Last updated on GMT

Related tags: Food and drug administration

Microbial Contamination Leads to Dr. Reddy's Recall
Five lots of a Dr Reddy’s manufactured gastric drug have been recalled due to microbial contamination.

The voluntary recall was announced last week by the US Food and Drug Administration (FDA) which said “a lot of raw material used in the manufacture of Ranitidine was positive for Pseudomonas sp."

The contaminated Ranitidine Hydrochloride Tablets – an over-the-counter drug used in gastric problems -  were manufactured at the Dr Reddy's facility in Bridgewater, New Jersey, US for distributors Wal-Mart, Supervalu and Walgreen.

Outsourcing-Pharma.com contacted India-based Dr. Reddy’s for further information but did not receive a response at the time of going to press.

Related news

Show more

Related products

show more

Has EDC Kept Up With Changes In Clinical Trials?

Has EDC Kept Up With Changes In Clinical Trials?

Oracle Health Sciences | 14-Dec-2020 | Technical / White Paper

In just a few decades, clinical trials have changed dramatically. Twenty years ago, most of the data used in clinical research was entered on paper, but...

Why Blister Packaging: Things to Consider

Why Blister Packaging: Things to Consider

Catalent Pharma Solutions | 03-Dec-2020 | Insight Guide

The decision to use blister packaging for either clinical trials or commercial drug manufacturing comes with a host of factors to consider. Pharmaceutical...

Related suppliers

Follow us

Products

View more

Webinars